The FDA has approved fFN testing for use as an aid in assessing the risk for preterm birth in women with or without symptoms of preterm labor.
IN THIS SECTION
An easy, 4-step procedure for collecting specimens, including instructions for ensuring accurate patient results.
Essential reimbursement codes associated with fFN.
Information for laboratory technologists, including step-by-step instructions for using the TLiIQ® System to provide test results to healthcare providers.
The QuikCheck fFN test is not approved for sales and marketing in the U.S. or licensed for sale in Canada.
A simple, reliable test that determines the risk of preterm birth.